Both in Pharmaceuticals
Xeris Biopharma Holdings vs Trevi Therapeutics
Over the past year XERS returned +4.5% and TRVI returned +29.5%; their daily moves had a correlation of 0.21.
XERS +4.5% TRVI +29.5%Growth of $1, one year, split-adjusted
| Metric | XERS | TRVI |
|---|---|---|
| Price | $10.35 | $13.86 |
| Market cap | $1.89B | $1.97B |
| Today | +1.77% | +1.69% |
| 1 month | +2.2% | +1.0% |
| 6 months | +66.1% | −5.5% |
| Year to date | +31.8% | +10.7% |
| 1 year | +6.7% | +18.9% |
| Revenue growth (YoY) | +28.7% | — |
| Gross margin | 86.4% | — |
| Net margin | −33.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 5.6× | — |
| Net cash | -$130.8M | $318.9M |
| Dividend yield | — | — |
| Volatility (60d) | 52.4% | 39.3% |
| Short % of float | 4.6% | 14.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).